Showing results (11-20 of 693) with videos related to
Sort By:
Pageof 70
Revue Medicale De Liege|February 24, 2001
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]A J ScheenRevue Medicale De Liege|April 19, 2000
[Clinical study of the month. The HOPE study, a two-by-two factorial clinical trial with contrasted results]A J ScheenRevue Medicale De Liege|December 6, 2000
[Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials]A J ScheenRevue Medicale De Liege|February 10, 2000
[Clinical study of the month. Does chronic sleep deprivation predispose to metabolic syndrome?]A J ScheenDrug Safety|December 12, 2001
Hepatotoxicity with thiazolidinediones: is it a class effect?A J ScheenRevue Medicale De Liege|August 30, 2003
[Medication of the month. Glucovance in type 2 diabetes, a fixed combination of metformin-glibenclamide for the treatment of a bipolar metabolic disease]A J ScheenRevue Medicale De Liege|September 6, 2019
[How I manage a patient with type 2 diabetes not well controlled with a metformin plus gliptin combination]A J ScheenRevue Medicale De Liege|August 26, 1998
[Drug clinics. Drug of the month. Atorvastatin (Lipitor)]A J ScheenRevue Medicale De Liege|August 5, 1998
[Pharmaco-economics of hypolipidemic agents: analysis of factors influencing the cost-effectiveness relation]A J ScheenRevue Medicale De Liege|June 10, 2005
["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease]A J ScheenPageof 70